GB201518375D0 - Agents,uses and methods - Google Patents

Agents,uses and methods

Info

Publication number
GB201518375D0
GB201518375D0 GBGB1518375.9A GB201518375A GB201518375D0 GB 201518375 D0 GB201518375 D0 GB 201518375D0 GB 201518375 A GB201518375 A GB 201518375A GB 201518375 D0 GB201518375 D0 GB 201518375D0
Authority
GB
United Kingdom
Prior art keywords
agents
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1518375.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Priority to GBGB1518375.9A priority Critical patent/GB201518375D0/en
Publication of GB201518375D0 publication Critical patent/GB201518375D0/en
Priority to JOP/2016/0135A priority patent/JO3711B1/en
Priority to TW105121106A priority patent/TWI741987B/en
Priority to MX2018000505A priority patent/MX2018000505A/en
Priority to CR20180026A priority patent/CR20180026A/en
Priority to BR112018000769-2A priority patent/BR112018000769A2/en
Priority to IL256791A priority patent/IL256791B/en
Priority to GEAP201614672A priority patent/GEP20227369B/en
Priority to NZ738595A priority patent/NZ738595A/en
Priority to UAA201800762A priority patent/UA123862C2/en
Priority to AU2016292892A priority patent/AU2016292892B2/en
Priority to EP16745421.4A priority patent/EP3322442A2/en
Priority to KR1020187001209A priority patent/KR20180030047A/en
Priority to RU2018100822A priority patent/RU2727911C2/en
Priority to JP2018501228A priority patent/JP6878395B2/en
Priority to SG10202101343RA priority patent/SG10202101343RA/en
Priority to MA042446A priority patent/MA42446A/en
Priority to CN201680040472.7A priority patent/CN107847595B/en
Priority to PCT/EP2016/066470 priority patent/WO2017009308A2/en
Priority to EA201890039A priority patent/EA038703B1/en
Priority to CA2990555A priority patent/CA2990555A1/en
Priority to PE2018000065A priority patent/PE20180607A1/en
Priority to US15/207,836 priority patent/US10196439B2/en
Priority to TNP/2017/000541A priority patent/TN2017000541A1/en
Priority to CONC2017/0013318A priority patent/CO2017013318A2/en
Priority to ZA2018/00070A priority patent/ZA201800070B/en
Priority to PH12018500062A priority patent/PH12018500062A1/en
Priority to NI201800005A priority patent/NI201800005A/en
Priority to DO2018000012A priority patent/DOP2018000012A/en
Priority to SV2018005611A priority patent/SV2018005611A/en
Priority to CL2018000096A priority patent/CL2018000096A1/en
Priority to ECIEPI20182644A priority patent/ECSP18002644A/en
Priority to HK18113433.8A priority patent/HK1254357A1/en
Priority to US16/188,489 priority patent/US10562962B2/en
Priority to US16/723,143 priority patent/US10934348B2/en
Priority to US17/144,355 priority patent/US11739140B2/en
Ceased legal-status Critical Current

Links

GBGB1518375.9A 2015-07-13 2015-10-16 Agents,uses and methods Ceased GB201518375D0 (en)

Priority Applications (36)

Application Number Priority Date Filing Date Title
GBGB1518375.9A GB201518375D0 (en) 2015-10-16 2015-10-16 Agents,uses and methods
JOP/2016/0135A JO3711B1 (en) 2015-07-13 2016-06-29 Antibodies specific for hyperphosphorylated tau and methods of use thereof
TW105121106A TWI741987B (en) 2015-07-13 2016-07-04 Antibodies specific for hyperphosphorylated tau and methods of use thereof
TNP/2017/000541A TN2017000541A1 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
MA042446A MA42446A (en) 2015-07-13 2016-07-12 SPECIFIC ANTIBODIES OF HYPERPHOSPHORYLATED TAU PROTEIN AND THEIR USE METHODS
CA2990555A CA2990555A1 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
BR112018000769-2A BR112018000769A2 (en) 2015-07-13 2016-07-12 hyperphosphorylated tau specific antibodies and methods for their use
IL256791A IL256791B (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
GEAP201614672A GEP20227369B (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
NZ738595A NZ738595A (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
UAA201800762A UA123862C2 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
AU2016292892A AU2016292892B2 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
EP16745421.4A EP3322442A2 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
KR1020187001209A KR20180030047A (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
RU2018100822A RU2727911C2 (en) 2015-07-13 2016-07-12 Antibodies, specific to hyperphosphorylated tau-protein, and methods of their application
JP2018501228A JP6878395B2 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and how to use them
SG10202101343RA SG10202101343RA (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
MX2018000505A MX2018000505A (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof.
CN201680040472.7A CN107847595B (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau protein and methods of use thereof
PCT/EP2016/066470 WO2017009308A2 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
EA201890039A EA038703B1 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau protein and methods of use thereof
CR20180026A CR20180026A (en) 2015-07-13 2016-07-12 SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND METHODS OF USE OF THE SAME.
PE2018000065A PE20180607A1 (en) 2015-07-13 2016-07-12 SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILATED TAU AND METHODS OF USE OF THEM
US15/207,836 US10196439B2 (en) 2015-07-13 2016-07-12 Antibodies specific for hyperphosphorylated tau and methods of use thereof
CONC2017/0013318A CO2017013318A2 (en) 2015-07-13 2017-12-22 Specific antibodies for hyperphosphorylated tau and methods of using the same
ZA2018/00070A ZA201800070B (en) 2015-07-13 2018-01-04 Antibodies specific for hyperphosphorylated tau and methods of use thereof
PH12018500062A PH12018500062A1 (en) 2015-07-13 2018-01-05 Antibodies specific for hyperphosphorylated tau and methods of use thereof
NI201800005A NI201800005A (en) 2015-07-13 2018-01-11 SPECIFIC ANTIBODIES FOR TAU HIP
DO2018000012A DOP2018000012A (en) 2015-07-13 2018-01-11 SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND METHODS OF USE OF THE SAME
SV2018005611A SV2018005611A (en) 2015-07-13 2018-01-11 SPECIFIC ANTIBODIES FOR HYPERFOSPHORILED TAU AND METHODS OF THE SAME USE
ECIEPI20182644A ECSP18002644A (en) 2015-07-13 2018-01-12 SPECIFIC ANTIBODIES FOR HYPERPHOSPHORYLATE TAU AND METHODS OF USE OF THEM
CL2018000096A CL2018000096A1 (en) 2015-07-13 2018-01-12 Specific antibodies for hyperphosphorylated tau and methods of use thereof.
HK18113433.8A HK1254357A1 (en) 2015-07-13 2018-10-19 Antibodies specific for hyperphosphorylated tau and methods of use thereof
US16/188,489 US10562962B2 (en) 2015-07-13 2018-11-13 Antibodies specific for hyperphosphorylated tau and methods of use thereof
US16/723,143 US10934348B2 (en) 2015-07-13 2019-12-20 Antibodies specific for hyperphosphorylated tau and methods of use thereof
US17/144,355 US11739140B2 (en) 2015-07-13 2021-01-08 Antibodies specific for hyperphosphorylated tau and methods of use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1518375.9A GB201518375D0 (en) 2015-10-16 2015-10-16 Agents,uses and methods

Publications (1)

Publication Number Publication Date
GB201518375D0 true GB201518375D0 (en) 2015-12-02

Family

ID=55131176

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1518375.9A Ceased GB201518375D0 (en) 2015-07-13 2015-10-16 Agents,uses and methods

Country Status (1)

Country Link
GB (1) GB201518375D0 (en)

Similar Documents

Publication Publication Date Title
HK1243741A1 (en) Tnfrsf-binding agents and uses thereof
IL255577B (en) Tigit-binding agents and uses thereof
GB201512203D0 (en) Agents,uses and methods
IL249370A0 (en) Fap-activated therapeutic agents, and uses related thereto
SG11201608943VA (en) Substituted 4-phenylpiperidines, their preparaiton and use
IL252430A0 (en) Antibodies, uses and methods
GB201616657D0 (en) Methods, compositions and uses relating thereto
GB201408673D0 (en) Medicaments,uses and methods
GB201612858D0 (en) New uses and methods
GB201616652D0 (en) Methods, compositions and uses relating thereto
GB201512215D0 (en) Agents,uses and methods
GB201603311D0 (en) New uses and methods
GB2548839B (en) New uses and methods
HK1247122A1 (en) Combinations and uses thereof
IL254241A0 (en) Etv2 and uses thereof
GB201616660D0 (en) Methods, compositions and uses relating thereto
GB201616674D0 (en) Methods, compositions and uses relating thereto
GB201616670D0 (en) Methods, compositions and uses relating thereto
GB201616666D0 (en) Methods, compositions and uses relating thereto
HUE047919T2 (en) Bioassimilable protein-melanin complex, preparation and uses
GB201518375D0 (en) Agents,uses and methods
GB201512211D0 (en) Agents, uses and methods
GB201512216D0 (en) Agents uses and methods
GB201616648D0 (en) Methods, compositions and uses relating thereto
GB201616647D0 (en) Methods, compositions and uses relating thereto

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)